Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification
Open Access
- 28 April 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (9) , 1452-1464
Abstract
Tumour stroma gene expression in biopsy specimens may obscure the expression of tumour parenchyma, hampering the predictive power of microarrays. We aimed to assess the utility of fluorescence-activated cell sorting (FACS) for generating cell populations for gene expression analysis and to compare the gene expression of FACS-purified tumour parenchyma to that of whole tumour biopsies. Single cell suspensions were generated from colorectal tumour biopsies and tumour parenchyma was separated using FACS. Fluorescence-activated cell sorting allowed reliable estimation and purification of cell populations, generating parenchymal purity above 90%. RNA from FACS-purified and corresponding whole tumour biopsies was hybridised to Affymetrix oligonucleotide microarrays. Whole tumour and parenchymal samples demonstrated differential gene expression, with 289 genes significantly overexpressed in the whole tumour, many of which were consistent with stromal gene expression (e.g., COL6A3, COL1A2, POSTN, TIMP2). Genes characteristic of colorectal carcinoma were overexpressed in the FACS-purified cells (e.g., HOX2D and RHOB). We found FACS to be a robust method for generating samples for gene expression analysis, allowing simultaneous assessment of parenchymal and stromal compartments. Gross stromal contamination may affect the interpretation of cancer gene expression microarray experiments, with implications for hypotheses generation and the stability of expression signatures used for predicting clinical outcomes.Keywords
This publication has 58 references indexed in Scilit:
- Matrix Metalloproteinase-activated Anthrax Lethal Toxin Demonstrates High Potency in Targeting Tumor VasculatureJournal of Biological Chemistry, 2008
- Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic toolsBMC Genomics, 2007
- Sequestosome 1/p62 – More than just a scaffoldFEBS Letters, 2006
- Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experimentsFEBS Letters, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- Human Colorectal Carcinogenesis Is Associated with Deregulation of Homeobox Gene ExpressionBiochemical and Biophysical Research Communications, 1997